发明申请
US20110086895A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS 有权
噻唑烷酮能量限制 - 物理试剂

THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS
摘要:
A method of inhibiting glycolysis in a subject by administering a pharmaceutical composition including a thiazolidinedione derivative to the subject is described. The thiazolidinedione derivatives are effective energy restriction mimetic agents, and can therefore be used to treat or prevent cancer in a subject, treat metabolic disorder, or increase the longevity of a subject. Various thiazolidinedione derivatives are also suitable for activating adenosine phosphate-activated protein kinase or inhibiting IL-6 expression.
公开/授权文献
信息查询
0/0